Our previous data showed that CD4+Foxp3+ Tregs rapidly reconstituted in HCT patients by a month after PTCy, preferentially survived PTCy in vitro, and were necessary for GVHD prevention immediately after PTCy in xenogeneic and MHC-matched HCT models (21, 22). This evidence concerns the gene CD4 and graft versus host disease.